Techno Drugs Ltd. (DSE:TECHNODRUG)
Bangladesh
· Delayed Price · Currency is BDT 27.80
-1.50 (-5.12%)
At close: Mar 8, 2026
Techno Drugs Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| Net Income | 205.53 | 232.02 | 280.6 | 195.51 | 479.78 |
| Depreciation & Amortization | 381.64 | 381.64 | 351.19 | 318.4 | 273.13 |
| Other Operating Activities | 186.78 | 38.67 | 0.38 | 53.81 | 21.63 |
| Change in Accounts Receivable | -181.62 | -181.62 | -169.25 | -82.53 | -224.72 |
| Change in Inventory | -247.26 | -247.26 | 82.27 | -292.5 | -184.72 |
| Change in Accounts Payable | -27.75 | -27.75 | -20.32 | 44.37 | 69.51 |
| Change in Other Net Operating Assets | -6.64 | -6.64 | -96.94 | -26.95 | 158.44 |
| Operating Cash Flow | 310.68 | 189.06 | 427.93 | 210.1 | 593.05 |
| Operating Cash Flow Growth | -7.82% | -55.82% | 103.68% | -64.57% | - |
| Capital Expenditures | -452.64 | -668.59 | -344.3 | -626.37 | -594.57 |
| Sale (Purchase) of Intangibles | -2.56 | -1 | -0.09 | -5.05 | - |
| Investment in Securities | 24.3 | 40.58 | 5.88 | -22.62 | 194 |
| Investing Cash Flow | -430.9 | -629 | -338.51 | -654.04 | -400.57 |
| Short-Term Debt Issued | - | - | - | 333.28 | - |
| Long-Term Debt Issued | - | 214.98 | 252.31 | 21.38 | 56.59 |
| Total Debt Issued | 594.56 | 214.98 | 252.31 | 354.65 | 56.59 |
| Short-Term Debt Repaid | - | -312.23 | -267.75 | - | -121.01 |
| Long-Term Debt Repaid | - | -19.23 | -19.44 | -10.06 | -20.05 |
| Total Debt Repaid | -741.06 | -331.46 | -287.19 | -10.06 | -141.06 |
| Net Debt Issued (Repaid) | -146.5 | -116.48 | -34.88 | 344.59 | -84.46 |
| Issuance of Common Stock | - | 738.46 | 261.54 | - | - |
| Common Dividends Paid | -45.19 | -49.42 | - | - | - |
| Other Financing Activities | 260.32 | -19.37 | -29.47 | -6.11 | -5.63 |
| Financing Cash Flow | 68.63 | 553.2 | 197.19 | 338.48 | -90.09 |
| Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 |
| Net Cash Flow | -51.59 | 113.26 | 286.61 | -105.47 | 102.39 |
| Free Cash Flow | -141.96 | -479.52 | 83.64 | -416.28 | -1.52 |
| Free Cash Flow Margin | -4.51% | -14.21% | 2.31% | -15.23% | -0.03% |
| Free Cash Flow Per Share | -1.07 | -3.64 | 0.88 | -4.42 | -0.02 |
| Cash Interest Paid | 395.48 | 401.56 | 322.87 | 252.1 | 5.63 |
| Cash Income Tax Paid | 23.91 | 24.68 | 88.99 | 15.85 | 155.24 |
| Levered Free Cash Flow | -106.4 | -822.37 | 47.09 | -468.59 | - |
| Unlevered Free Cash Flow | 157.62 | -565.2 | 238.3 | -303.67 | - |
| Change in Working Capital | -463.27 | -463.27 | -204.24 | -357.61 | -181.49 |
Source: S&P Capital IQ. Standard template. Financial Sources.